Bioactive streptomyces-derived silver nanoparticles enhance antibacterial activity against cephalosporin-resistant Escherichia coli and Klebsiella through membrane disruption and in vivo efficacy
Microbial Pathogenesis · 2026
DOI: 10.1016/j.micpath.2026.108806 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2026. Verfasst von Mohammed Alissa. Beteiligte Einrichtung: Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj, 11942, Saudi Arabia. Electro…. Hauptthemen laut MEDLINE: Streptomyces, Silver, Anti-Bacterial Agents, Escherichia coli. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Prince Sattam bin Abdulaziz University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj, 11942, Saudi Arabia. Electronic address: m.alissa@psau.edu.sa.
Förderung
- Prince Sattam bin Abdulaziz University
Zitieren
APA
Alissa, M. (2026). Bioactive streptomyces-derived silver nanoparticles enhance antibacterial activity against cephalosporin-resistant Escherichia coli and Klebsiella through membrane disruption and in vivo efficacy. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2026.108806
Vancouver
Alissa M. Bioactive streptomyces-derived silver nanoparticles enhance antibacterial activity against cephalosporin-resistant Escherichia coli and Klebsiella through membrane disruption and in vivo efficacy. Microbial Pathogenesis. 2026. doi:10.1016/j.micpath.2026.108806
BibTeX
@article{Alissa2026,
author = {Alissa, Mohammed},
title = {Bioactive streptomyces-derived silver nanoparticles enhance antibacterial activity against cephalosporin-resistant Escherichia coli and Klebsiella through membrane disruption and in vivo efficacy},
journal = {Microbial Pathogenesis},
year = {2026},
doi = {10.1016/j.micpath.2026.108806}
}
EUVIMED